Fred Hutchinson Cancer Center

Quick facts

Marketed products

• Atripla or Stribild · Infectious Disease / Virology
  Atripla and Stribild are fixed-dose combination antiretroviral drugs that inhibit HIV replication through multiple mechanisms targeting reverse transcriptase and integrase.
• Beta Carotene and Retinol
• Garlic oil
• JAK Inhibitor · Oncology, Immunology
  JAK inhibitors block Janus kinase enzymes, which are intracellular signaling proteins that transmit inflammatory and immune signals from cell surface receptors.
• Nicotine Gum
• Nicotine Lozenge
• Recombinant Granulocyte Colony-Stimulating Factor

Phase 3 pipeline

• endocrine-modulating drug therapy · Oncology
  Endocrine-modulating drug therapy works by modulating the body's endocrine system to treat various conditions.
• Liposome-encapsulated Daunorubicin-Cytarabine · Oncology
  A liposome-encapsulated combination of two chemotherapy drugs (daunorubicin and cytarabine) that delivers cytotoxic agents directly into leukemic cells to inhibit DNA synthesis and induce cell death.

Phase 1 pipeline

• T-cell Receptor-engineered T-cells
• TLR4 Agonist GLA-SE
• Wistar Rabies Virus Strain PM-1503-3M Vaccine

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Fred Hutchinson Cancer Center portfolio CI brief
• Fred Hutchinson Cancer Center pipeline updates RSS

Frequently asked questions about Fred Hutchinson Cancer Center

Related

• Atripla or Stribild · Infectious Disease / Virology
• Beta Carotene and Retinol
• Garlic oil
• JAK Inhibitor · Oncology, Immunology
• Nicotine Gum
• Sector hub: All tracked pharma companies